Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Cantourage Aktie 122952903 / DE000A3DSV01

01.10.2025 09:47:53

EQS-News: Cantourage Strengthens Capital Markets Presence: New Head of Investor Relations and Strategic Focus on Europe

EQS-News: Cantourage Group SE / Key word(s): Personnel
Cantourage Strengthens Capital Markets Presence: New Head of Investor Relations and Strategic Focus on Europe

01.10.2025 / 09:47 CET/CEST
The issuer is solely responsible for the content of this announcement.


Not for release, publication or distribution, directly or indirectly, in or into the United States of America, Australia, Canada or Japan or any other jurisdiction in which such release, publication or distribution would be unlawful. The important notices at the end of this release must be observed.

 

Berlin, October 1, 2025 – Cantourage Group SE (ISIN: DE000A3DSV01, “Cantourage”) today announced a significant step in expanding its capital markets presence. Manuel Taverne, a seasoned capital markets professional, has been appointed as Head of Investor Relations. In this role, he will lead Cantourage’s investor relations activities with a particular focus on strengthening engagement across European financial markets.

With more than 20 years of experience in capital markets and strategic financial communications, Mr. Taverne brings deep expertise in building and maintaining strong investor relations. His appointment underlines Cantourage’s commitment to proactively advancing its capital markets strategy and fostering closer ties with institutional and private investors alike.

“By bringing Manuel Taverne on board, we gain an accomplished capital markets expert with outstanding knowledge and extensive experience. I am excited to work with him as we continue to expand our investor engagement,” said Philip Schetter, CEO of Cantourage.

Cantourage’s goal is to more clearly communicate its position as one of Europe’s leading providers of medical cannabis to the investment community. “Our innovative business model and platform strategy set us apart from the competition – yet the uniqueness of our approach has not been fully recognized by the market to date,” Schetter continued. “That is why we are intensifying our investor relations efforts – to present our equity story with greater clarity, transparency, and proactivity.”

fncls.ssp?fn=download2_file&code_str=b12d132d5975a34257e41b3a1e85f2bb

Cantourage CEO Philip Schetter (left) and Manuel Taverne


About Cantourage

Cantourage is a leading European company for the production and distribution of medical cannabis. Cantourage enables growers worldwide to sell products in European medical markets. Founded in 2019, the company works with more than 60 cannabis growers from 18 countries. Cantourage ensures the highest pharmaceutical quality standards along the value chain and offers products in all relevant market segments: dried flowers, extracts, dronabinol and cannabidiol. The company has been listed on the Frankfurt Stock Exchange since November 11, 2022 and is listed under the ticker symbol “HIGH”.

More information: www.cantourage.com

This announcement does not constitute an offer to the public or a solicitation of anoffer to sell securities to the public, in particular not within the meaning ofRegulation (EU) 2017/1129 (Prospectus Regulation).



01.10.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Cantourage Group SE
Feurigstrasse 54
10827 Berlin
Germany
E-mail: info@cantourage.com
Internet: https://www.cantourage.com/
ISIN: DE000A3DSV01
WKN: A3DSV0
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Scale), Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2206750

 
End of News EQS News Service

2206750  01.10.2025 CET/CEST

Analysen zu Cantourage

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Let’s talk about Börsenjahr 2025 | Börsentag Zürich 2025

Ein besonderes Highlight des Börsentag Zürich 2025 war die grosse Diskussionsrunde mit:
👉 Thomas B. Kovacs (Sparkojote)
👉 Robert Halver (Baader Bank)
👉 Tim Schäfer (Finanzblogger, New York)
👉 Lars Erichsen (Börsencoach & YouTuber)
👉 David Kunz (COO, BX Swiss)

Gemeinsam analysieren sie die Entwicklungen an den Finanzmärkten 2025, teilen Einschätzungen zu aktuellen Trends und geben spannende Einblicke für Anleger.

📌 Themen im Fokus:
🔹Welche Krisen & geopolitischen Risiken beschäftigen die Märkte wirklich?
🔹Wie wirken sich Zölle speziell auf die Schweiz und ihre Exportwirtschaft aus?
🔹Zinspolitik: Unterschiede zwischen USA, Europa und Schweiz.
🔹Aktien vs. Immobilien: Welche Assetklasse lohnt sich 2025 mehr?
🔹Künstliche Intelligenz – Hype oder langfristiger Wachstumstreiber?
🔹Gold vs. Bitcoin: Welches Asset ist der bessere Schutz im Depot?
🔹Inflation, Liquidität und Notenbanken: Warum Sachwerte profitieren.
🔹Blick in die Glaskugel: Wo stehen Aktien & Krypto Ende 2025?

Ein besonderes Highlight auf dem diesjährigen Börsentag Zürich war die BX Swiss Blogger-Lounge. Bekannte YouTuber und Finanz-Influencer standen für Gespräche und Diskussionen bereit und vermittelten Ihr Wissen und Ihre Erfahrungen in Vorträgen.

👉🏽 Jetzt auch auf BXplus anmelden und von exklusiven Inhalten rund um Investment & Trading profitieren!

Krise überall – Börse steigt trotzdem! | Börsentag Zürich 2025

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’858.56 18.98 S2S3VU
Short 13’097.24 13.86 B7ZS2U
Short 13’575.18 8.97 BTASKU
SMI-Kurs: 12’354.04 01.10.2025 17:30:00
Long 11’809.67 19.12 SQFBLU
Long 11’548.84 13.70 BXGS2U
Long 11’036.43 8.75 BQFSFU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}